Germ-line BRCA1 mutations in selected men with prostate cancer.
暂无分享,去创建一个
J. D. Thompson | J. Thompson | J. Stanford | E. Ostrander | R. Blazej | K. Wicklund | E A Ostrander | J L Stanford | A A Langston | J D Thompson | K G Wicklund | R G Blazej | A. Langston | A. A. Langston
[1] A. Whittemore,et al. Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. , 1995, American journal of epidemiology.
[2] T H Beaty,et al. Risk of cancer in relatives of prostate cancer probands. , 1995, Journal of the National Cancer Institute.
[3] T. Sellers,et al. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. , 1994, Journal of the National Cancer Institute.
[4] D. Anderson,et al. Breast cancer risks in relatives of male breast cancer patients. , 1992, Journal of the National Cancer Institute.
[5] F. Collins,et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals , 1995, Nature Genetics.
[6] E. U. Thiessen,et al. Concerning a familial association between breast cancer and both prostatic and uterine malignancies , 1974, Cancer.
[7] B. Harlow,et al. Two one-step methods for household screening and interviewing using random digit dialing. , 1988, American journal of epidemiology.
[8] Patrick Dowd,et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families , 1994, Nature Genetics.
[9] J. Rommens,et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families , 1994, Nature Genetics.
[10] R. Barkardottir,et al. Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer. , 1993, American journal of human genetics.
[11] M. Skolnick,et al. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening. , 1995, JAMA.
[12] T. Beaty,et al. Mendelian inheritance of familial prostate cancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. King,et al. Mutation analysis of the BRCA1 gene in ovarian cancers. , 1995, Cancer research.
[14] P. Tonin,et al. BRCA1 mutations in Ashkenazi Jewish women. , 1995, American journal of human genetics.
[15] M. Badzioch,et al. Familial breast cancer risks. Effects of prostate and other cancers , 1993, Cancer.
[16] J. D. Thompson,et al. BRCA1 mutations in a population-based sample of young women with breast cancer. , 1996, The New England journal of medicine.
[17] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[18] R. Glass,et al. Frontometaphyseal dysplasia: neonatal radiographic diagnosis. , 1995, American journal of medical genetics.
[19] M. King,et al. Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.
[20] D. Easton,et al. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.
[21] G. Olafsdóttir,et al. Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. , 1992 .
[22] D. Easton,et al. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. , 1995, American journal of human genetics.
[23] D. Easton,et al. Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.